Bribery, Fraud & Tax Evasion

State securities officials have charged units of Dutch financial services giant ING Groep NV with taking undisclosed payments for promoting poor investments to state employees in their individual retirement plans.
The Commodity Futures Trading Commission fined a top oil trader at Royal Dutch Shell PLC and one of the energy titan's trading subsidiaries a combined $300,000 for a series of bogus oil-futures trades on the New York Mercantile Exchange.
The controversial multibillion-dollar deal with oil services giant Halliburton to provide logistical support to U.S. troops in Iraq has been canceled. What should happen next? Read our three alternative annual reports on Halliburton, to learn the real legacy of the company's incompetence and corruption.Listen to an interview with CorpWatch's director, Pratap Chatterjee.
In the wake of the Bernard Madoff Ponzi scheme scandal, the SEC has brought cases involving losses of over $200 million since the beginning of October last year, including one against the disgraced Democratic donor Norman Hsu and North Carolina-based Biltmore Financial.
As New York Attorney General Eliot Spitzer charges American International Group (AIG) executives with collusion in an insurance brokerage kickback scandal, a paper trail stretching back a decade reveals that AIG used offshore shell companies to skirt the law.
Kyle "Dusty" Foggo, the former No. 3 official in the CIA, pleaded guilty yesterday to fraudulently steering intelligence contracts to his lifelong friend, former Poway defense contractor Brent Wilkes.
A new study, issued by scientists at the Freeman Spogli institute at Stanford university in California, that suggests that organic food has no medical or health values is deeply flawed, say outraged activists.
A former banker at UBS AG pleaded guilty in federal court to helping a billionaire client evade taxes by hiding $200 million in assets in offshore accounts, in a move expected to aid U.S. prosecutors in their probe of the Swiss banking giant.
A procedure designed to alert the Food and Drug Administration to scientific and safety issues is getting a hard look from members of Congress, who say they are concerned that it may be getting subverted by the brand-name drug industry.
A huge state-owned Chinese pharmaceutical company that exports to dozens of countries, including the United States, is at the center of a nationwide drug scandal after nearly 200 Chinese cancer patients were paralyzed or otherwise harmed last summer by contaminated leukemia drugs.